Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2.

Becker, Jürgen

Neuroblastoma progression correlates with downregulation of the lymphangiogenesis inhibitor sVEGFR-2. [electronic resource] - Clinical cancer research : an official journal of the American Association for Cancer Research Mar 2010 - 1431-41 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1557-3265

10.1158/1078-0432.CCR-09-1936 doi


Disease Progression
Down-Regulation
Enzyme-Linked Immunosorbent Assay
Humans
Lymphangiogenesis--genetics
N-Myc Proto-Oncogene Protein
Neoplasm Invasiveness--genetics
Neoplasm Staging
Neuroblastoma--genetics
Nuclear Proteins--genetics
Oncogene Proteins--genetics
Reverse Transcriptase Polymerase Chain Reaction
Vascular Endothelial Growth Factor A--genetics
Vascular Endothelial Growth Factor C--genetics
Vascular Endothelial Growth Factor D--genetics
Vascular Endothelial Growth Factor Receptor-1--genetics
Vascular Endothelial Growth Factor Receptor-2--genetics
Vascular Endothelial Growth Factor Receptor-3--genetics